Inhibition of Moesin and CD44 in stem cell‐derived neurons affects the pathological genetic signature associated with Alzheimer's disease
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71734 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Eiden H Brewer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurons, Hyaluronan Receptors, Induced Pluripotent Stem Cells. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Post mortem proteomic analysis of Alzheimer's disease (AD) brain tissue has identified novel target genes and proteins for potential therapeutic development. Moesin ( MSN ) and CD44 were identified as candidate targets. Using human induced pluripotent stem cells (hiPSCs)‐derived neurons, we assayed how reducing gene expression of MSN and CD44 affected amyloid beta secretion, tau phosphorylation, and transcriptional state. METHODS Knockdown of MSN and CD44 in hiPSC‐derived neurons was performed using short hairpin RNA (shRNA). Amyloid precursor protein processing and intracellular tau phosphorylation was measured using chemiluminescent ELISA assays. Global gene expression was analyzed by bulk RNA sequencing (RNA‐seq). RESULTS Knockdown of CD44 and MSN increased secretion of amyloid beta and soluble APP beta and differentially altered tau generation and phosphorylation. RNA‐seq revealed diverse effects of CD44 and MSN knockdown and the reversal of some expression shifts found in late‐onset AD. DISCUSSION These findings connect reduced CD44 and MSN expression to AD‐related signatures in neurons and inform their role in the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
- Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington, USA.
- Neurobiology, Neurodegeneration & Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA.
- The Jackson Laboratory, Bar Harbor, Maine, USA.
- Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA.
- Emory Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, Georgia, USA.
ORCID-Profile: Jessica E Young
Förderung
- NIA NIH HHS
- National Institute on Aging
Zitieren
APA
Brewer, E. H., Williams, C. A., Cary, G. A., Betarbet, R., Pranoto, I. K. A., Zoeller, E. L., Fu, H., Levey, A. I., Wiley, J. C., Carter, G. W., Young, J. E., & TREAT‐AD Consortium (2026). Inhibition of Moesin and CD44 in stem cell‐derived neurons affects the pathological genetic signature associated with Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71734
Vancouver
Brewer EH, Williams CA, Cary GA, Betarbet R, Pranoto IKA, Zoeller EL, et al. Inhibition of Moesin and CD44 in stem cell‐derived neurons affects the pathological genetic signature associated with Alzheimer's disease. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71734
BibTeX
@article{Brewer2026,
author = {Brewer, Eiden H and Williams, Charles A and Cary, Gregory A and Betarbet, Ranjita and Pranoto, Inez K A and Zoeller, Elizabeth L and Fu, Haian and Levey, Allan I and Wiley, Jesse C and Carter, Gregory W and Young, Jessica E and TREAT‐AD Consortium, TREAT‐AD Consortium},
title = {Inhibition of Moesin and CD44 in stem cell‐derived neurons affects the pathological genetic signature associated with Alzheimer's disease},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71734}
}
EUVIMED